Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2002

View Archived Issues

Memantine induces neuroprotection in rats and is effective for treating dementia in humans

Synthesis and efficacy of two novel orally active antimalarial synthetic 3-carboxyphenyltrioxanes

Periostat enters phase III trial for the treatment of rosacea

CAT and Xerion enter allergy target research collaboration

VitrenASE enters phase II trial in proliferative vitreoretinopathy

Pivotal Alprox-TD studies complete enrollment

Growth hormone reverses thymic atrophy in HIV-infected men

Antithrombotic efficacy of MAb-LE2E9 shown in a murine model of venous thrombosis

Skin permeation of miconazole is enhanced by hydrogenated soybean lecithin and DDAIP formulations

New hypolipidemic agents emerging from Aventis R&D

New erythromycin A derivatives in early development at GSK

Lilly claims sPLA2 inhibitors with potential in sepsis and other inflammatory disorders

Selective procollagen C-proteinase inhibitors presented by Pfizer

Antioxidant epicatechin derivatives for use in cancer, cardiovascular disorders, etc.

Elidel receives positive health authority decision in 13 European countries

OSI and Genentech update progress of Tarceva development program

Results on FTase inhibitor SCH-400 presented at ACS

Merck reports novel KDR inhibitors at ACS meeting

In vitro and in vivo characterization of new KDR inhibitors disclosed by Merck

Wyeth scientists identify novel inhibitors of B7.1-CD28 interaction

New cathepsin S inhibitors designed by Boehringer Ingelheim researchers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...